06/19/2017
https://www.congress.gov...
"While drug pricing is outside of the FDA's jurisdiction and the most robust solutions likely involve HHS and CMS, this is something this committee needs to address this Congress."
"Do you share her view that a budget cut of that magnitude to the NIH would be devastating to medical innovation?"
"Patients and families in my home State of Washington and nationwide deserve to know the devices used in their care are safe and effective, and I'm going to continue fighting for this until we get mean..."
"Let's be clear. Those tweaks alone will not solve the problem. More work is needed outside the FDA context and outside this committee's jurisdiction to address the root cause of high prices."